Benefits of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler in Patients with Moderate Chronic Obstructive Pulmonary Disease in the ETHOS Study

被引：0
|
作者：
Ferguson, G. T. [1 ]
Rabe, K. F. [2 ,3 ,4 ]
Singh, D. [5 ]
Jenkins, M. [6 ]
Patel, M. [6 ]
Aurivillius, M. [7 ]
机构：
[1] Pulm Res Inst Southeast Michigan, Farmington Hills, MI USA
[2] LungenClin Grosshansdorf, Grosshansdorf, Germany
[3] Christian Albrechts Univ Kiel, Airway Res Ctr North, Grosshansdorf, Germany
[4] German Ctr Lung Res DZL, Grosshansdorf, Germany
[5] Univ Manchester, Manchester Univ NHS Fdn Hosp Trust, Med Evaluat Unit, Manchester, Lancs, England
[6] AstraZeneca, Cambridge, England
[7] AstraZeneca, Gothenburg, Sweden
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 203卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2244
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A scintigraphy study of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in patients with moderate-to-very severe chronic obstructive pulmonary disease
    Usmani, Omar
    Roche, Nicolas
    Wahab, Ezanul
    Israel, Samuel
    Jenkins, Martin
    Trivedi, Roopa
    Dorinsky, Paul
    Aurivillius, Magnus
    RESPIRATORY RESEARCH, 2021, 22 (01)
  • [2] A scintigraphy study of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in patients with moderate-to-very severe chronic obstructive pulmonary disease
    Omar Usmani
    Nicolas Roche
    Ezanul Wahab
    Samuel Israel
    Martin Jenkins
    Roopa Trivedi
    Paul Dorinsky
    Magnus Aurivillius
    Respiratory Research, 22
  • [3] Benefits of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler in Patients with Chronic Obstructive Pulmonary Disease by Baseline CAT Score: Post-Hoc Analysis of the ETHOS Study
    Hurst, J.
    Martinez, F. J.
    Singh, D.
    Darken, P.
    Patel, M.
    Dorinsky, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [4] Benefits of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) on Symptoms and Quality of Life in Patients with Chronic Obstructive Pulmonary Disease (COPD) in the ETHOS Trial
    Martinez, F. J.
    Rabe, K. F.
    Ferguson, G. T.
    Wedzicha, J. A.
    Trivedi, R.
    St Rose, E.
    Ballal, S.
    Darken, P.
    Aurivillius, M.
    Dorinsky, P.
    Reisner, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [5] Budesonide/Glycopyrrolate/Formoterol Fumarate Co-suspension Metered Dose Inhaler: A Triple Therapy for the Treatment of Chronic Obstructive Pulmonary Disease
    Nigro, Stefanie C.
    Sobieraj, Diana M.
    ANNALS OF PHARMACOTHERAPY, 2022, 56 (05) : 582 - 591
  • [6] Budesonide/Formoterol Pressurized Metered-Dose Inhaler In Chronic Obstructive Pulmonary Disease
    Lyseng-Williamson, Katherine A.
    DRUGS, 2009, 69 (11) : 1459 - 1470
  • [7] Effectiveness of Budesonide/Glycopyrrolate/Formoterol Fumarate in Chinese Patients With Chronic Obstructive Pulmonary Disease
    Sun, Y.
    Chen, Y.
    Zhou, L.
    Zhang, X.
    Guo, R.
    Feng, J.
    Xiong, X.
    Li, G.
    Xu, W.
    Zhang, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [8] An Open-Label Study Evaluating the Performance of the Dose Indicator in a Metered Dose Inhaler Delivering Glycopyrrolate and Formoterol Fumarate in Patients with Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease
    Pudi, Krishna
    Feldman, Gregory
    Fakih, Faisal
    Mack, Peter
    Maes, Andrea
    Siddiqui, Shahid
    St Rose, Earl
    Reisner, Colin
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2019, 32 (01) : 40 - 46
  • [9] Improvements in lung function with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler versus dual therapies in patients with COPD: a sub-study of the ETHOS trial
    Rabe, Klaus F.
    Martinez, Fernando J.
    Singh, Dave
    Trivedi, Roopa
    Jenkins, Martin
    Darken, Patrick
    Aurivillius, Magnus
    Dorinsky, Paul
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2021, 15
  • [10] FUNCTIONAL RESPIRATORY IMAGING ASSESSMENT OF BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL FUMARATE AND GLYCOPYRROLATE/FORMOTEROL FUMARATE METERED DOSE INHALERS IN PATIENTS WITH COPD
    van den Berge, M.
    De Backer, Jan
    Van Holsbeke, Cedric
    De Backer, Wilfried
    Trivedi, Roopa
    Jenkins, Martin
    Dorinsky, Paul
    Aurivillius, Magnus
    CHEST, 2020, 158 (04) : 1782A - 1783A
12345